FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

6 letters match. Newest first.

  1. Tianjin Healthcare Medical Technology Co., Ltd.

    Chinese API maker refused FDA records requests, and all its drugs now face a US import alert.

    High risk
  2. Pure Indulgence Aesthetics

    Drug Supply Chain Security Act (DSCSA) Violations

  3. Flowchem Pharma Private Limited

    FDA warned India's Flowchem Pharma over dirty API equipment, exposed materials and untested impurities, and blocked its drug imports.

    High risk
  4. My Holistic Honey c/o Shenzhen Qanhai Wanb Express Supply Chain Co., LTD

    Unapproved New Drugs/Ophthalmic Drug Products

  5. Sterling Distributors

    Drug Supply Chain Security Act (DSCSA) Violations

  6. Inmar Supply Chain Solutions, LLC

    CGMP/Manufacturing, Packing or Holding Human Food/Adulterated/Insanitary Conditions